Skip to content
Research Article Open access CC BY 4.0

‘Spread’ of Artemisinin Resistance in Myanmar Revisited

Eric P. M. Grist

International Journal of TROPICAL DISEASE & Health · pp. 1–16 · Published 1 Aug 2022

10.9734/ijtdh/2022/v43i1530643

Abstract

Geostatistical models have been widely used to represent disease prevalence in spatial disease mapping. More recently, these models have been employed to estimate geographic ‘spread’ of artemisinin resistance (AR) in South East Asia from genetic mutations identified in the K13 gene of the malaria Plasmodiumfalciparum parasite. Here, I revisit the question of ‘spread’ of AR as represented by resistant plasmodiumfalciparum in Myanmar, when re-evaluated from K13 mutant alleles data published by Tun et al. [1]. The new analysis gives a broader perspective by incorporating information published by the World Health Organization (WHO) in 2015 and subsequently in 2018 of the K13 mutant alleles confirmed to confer or to be associated with artemisinin resistance. This provides insights which hitherto have not been described and reveals the disparity between the estimation of ‘spread’ of AR by Tun et al. [1] and that of AR prevalence based on metrics which are supported by published WHO data.

K13 genetic markers overestimation prevalence malaria antimalarial drug resistance

Cited by 1

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.